Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A startup is targeting diseases including cancer using epigenetic approaches.
Understanding the different populations of mutant cells in a cancer could mean more targeted treatments.
Scientists use synthetic biology to create drug-controlled T cells.
Sequencing the genomes of both healthy and cancer cells from the same patient hints at how cancer metastasizes.
A number of dual-action antibodies are in clinical trials for fighting cancer.
By automating the tracking of tumor cells that circulate in the blood, doctors can see if a cancer treatment is working.
In first human trial, particles successfully reach cancer cells and silence the target gene.
Molecules that make blood vessels more permeable might boost chemotherapeutics.
The fluorescent molecule targets tumors to guide surgeons and provide pre- and post-op imaging.